Skip to main content
HERAMED LIMITED logo

HERAMED LIMITED — Investor Relations & Filings

Ticker · HMD ISIN · AU0000028367 LEI · 875500WOB41XBFTTJ477 ASX Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2019-12-09 Capital/Financing Update
Country AU Australia
Listing ASX HMD

About HERAMED LIMITED

https://hera-med.com/

HeraMED Limited is a medical technology company specializing in the development and commercialization of digital health solutions for maternity care. The company focuses on providing remote monitoring tools that bridge the gap between expectant mothers and healthcare providers. Its flagship product, HeraBEAT, is a medical-grade, smartphone-based fetal heart rate monitor designed for home use, allowing for accurate and reliable monitoring of fetal well-being. This hardware is integrated into the HeraCARE platform, a comprehensive digital maternity care solution that enables remote data management, personalized care plans, and seamless communication between patients and clinicians. By leveraging cloud-based technology and advanced sensors, the company aims to enhance prenatal care, improve clinical outcomes, and offer peace of mind through continuous, data-driven insights throughout the pregnancy journey.

Recent filings

Filing Released Lang Actions
A$1.42m strategic placement completed to expedite US entry 2 pages 143.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 10 December 2019 regarding a strategic placement of shares to raise A$1.42 million. It details the use of funds for business development, US market entry, clinical trials, and rollout in other markets. The text focuses on the completion of a capital raising event and the intended use of proceeds. There are no financial statements, quarterly or annual results, or detailed financial analysis present. The document is a corporate announcement about financing activity rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 4653 characters, which is consistent with a detailed announcement but not a full report.
2019-12-09 English
Trading Halt 2 pages 444.7KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from HeraMED Limited regarding a trading halt requested pending a capital raising announcement. It references ASX Listing Rule 17.1 and states that the trading halt is requested until the announcement of a capital raising is made. The document is short (2831 characters) and does not contain any financial statements or detailed financial data. It is an announcement about a trading halt related to capital raising, not the capital raising update itself. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to financing activities and capital structure changes.
2019-12-05 English
New CPT codes allow for potential reimbursement in USA 2 pages 170.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 4 December 2019 from HeraMED Limited. It discusses new CPT codes for potential reimbursement in the USA for their medical devices and platforms. The content focuses on the company's plans to pursue verification of reimbursement eligibility and provides background on the CPT codes and FDA clearance. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is an announcement about a business development related to reimbursement codes and market entry strategy, not a financial report or regulatory filing. It is not a report publication announcement since it does not mention any report being attached or published. Therefore, the document fits best into the category of a Regulatory Filing (RNS) as a general announcement that does not fit other specific categories.
2019-12-03 English
2020 Company Outlook 28 pages 10.1MB
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation' and is explicitly described as an updated company presentation to investors. It contains detailed information about the company's business model, partnerships, market opportunity, product development, and reimbursement codes, typical of investor presentations. There is no indication that this is a regulatory filing, earnings release, or annual/interim report. The document is about 15,000 characters long, which is consistent with a detailed presentation. It is not a report publication announcement or a certification. Therefore, the document fits the category of an Investor Presentation (IP).
2019-12-01 English
Appendix 3B and ASX Escrow Release 16 pages 685.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 28 November 2019 concerning the issuance of new shares and the release of securities from escrow. It prominently features an Appendix 3B, which is a standard form used in Australian securities markets for new issue announcements and applications for quotation of additional securities. The content details the number and class of securities issued, escrow periods, and related regulatory compliance information. There is no financial performance data, management discussion, or earnings information. The document is regulatory in nature, focused on capital issuance and securities listing matters. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is not merely a brief announcement or report publication notice but a full regulatory filing about capital changes.
2019-11-27 English
Change of Director's Interest Notice - David Groberman 3 pages 163.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including number of shares held before and after the change, nature of the change, and related contract information. This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trades or director dealings. It is not an annual report, earnings release, or any other financial report type. Therefore, the document fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual notice, not just an announcement or certification.
2019-11-27 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.